Isukuba, Japan

Shigeru Uchiyama

This inventor holds 1 USPTO granted patent. Top assignee: Banyu Pharmaceutical Co. Ltd. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigeru Uchiyama. Retrieved from https://idiyas.com/inventor/shigeru-uchiyama-e7g07f5t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shigeru Uchiyama: Innovator in Antifungal Substances

Introduction

Shigeru Uchiyama is a notable inventor based in Isukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal substances. His work has been recognized for its potential impact on medical treatments.

Latest Patents

Uchiyama holds a patent for antifungal substances known as BE-49385, along with the process for their production. This innovation represents a crucial advancement in the fight against fungal infections, showcasing his expertise in pharmaceutical research.

Career Highlights

Uchiyama is associated with Banyu Pharmaceutical Co. Ltd., where he has been instrumental in various research initiatives. His dedication to developing effective medical solutions has earned him respect in the pharmaceutical community.

Collaborations

Throughout his career, Uchiyama has collaborated with esteemed colleagues, including Hiroshi Kushida and Shigeru Nakajima. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Shigeru Uchiyama's contributions to antifungal research exemplify the importance of innovation in the pharmaceutical industry. His work continues to influence the development of effective treatments for fungal infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…